Literature DB >> 9203932

Cholecystokinin in transient lower oesophageal sphincter relaxation due to gastric distension in humans.

J Boulant1, S Mathieu, M D'Amato, A Abergel, M Dapoigny, G Bommelaer.   

Abstract

BACKGROUND AND AIMS: Transient lower oesophageal sphincter relaxations (TLOSRs) has been found to be the main mechanism of gastro-oesophageal reflux. In dogs, cholecystokinin (CCK) is involved in their occurrence. The aim was to evaluate the role of endogenous and exogenous CCK in the occurrence of TLOSRs induced by gastric distension at constant pressure in humans.
METHODS: Ten healthy volunteers were studied. Lower oesophageal sphincter pressure was monitored with a sleeve device and gastric distension was performed via an intragastric bag monitored by a barostat. During distensions, saline, CCK (30 ng/kg/h) or the CCK-A receptor antagonist loxiglumide (10 mg/kg/h) was perfused in a random double blind order.
RESULTS: There was no significant difference between the number of TLOSRs during the different distensions with saline; CCK increased the number of TLOSRs at a mean rate of 13.1 compared with 9.1 with saline (p < 0.001). Loxiglumide significantly decreased the number of relaxations to 5.3 versus 8.3 under paired saline infusion (p < 0.001).
CONCLUSIONS: In humans, CCK-A receptor subtype is involved in the occurrence of transient lower oesophageal sphincter relaxations induced by gastric distension.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9203932      PMCID: PMC1027156          DOI: 10.1136/gut.40.5.575

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  34 in total

1.  Control of belching by the lower oesophageal sphincter.

Authors:  J B Wyman; J Dent; R Heddle; W J Dodds; J Toouli; J Downton
Journal:  Gut       Date:  1990-06       Impact factor: 23.059

2.  Effects of a cholecystokinin receptor antagonist on intestinal phase of pancreatic and biliary responses in man.

Authors:  P Hildebrand; C Beglinger; K Gyr; J B Jansen; L C Rovati; M Zuercher; C B Lamers; I Setnikar; G A Stalder
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

3.  Response of canine lower esophageal sphincter to gastric distension.

Authors:  S J Franzi; C J Martin; M R Cox; J Dent
Journal:  Am J Physiol       Date:  1990-09

4.  Simultaneous assessment of liquid emptying and proximal gastric tone in humans.

Authors:  A Ropert; S B des Varannes; Y Bizais; C Rozé; J P Galmiche
Journal:  Gastroenterology       Date:  1993-09       Impact factor: 22.682

5.  Effects of cholecystokinin (CCK-8) on two classes of gastroduodenal vagal afferent fibre.

Authors:  L A Blackshaw; D Grundy
Journal:  J Auton Nerv Syst       Date:  1990-12

6.  Effect of cholestyramine and cholecystokinin receptor antagonist CR1505 (loxiglumide) on lower esophageal sphincter pressure in man.

Authors:  A A Masclee; J B Jansen; L C Rovati; C B Lamers
Journal:  Dig Dis Sci       Date:  1993-10       Impact factor: 3.199

7.  Central distribution of subdiaphragmatic vagal branches in the rat.

Authors:  R Norgren; G P Smith
Journal:  J Comp Neurol       Date:  1988-07-08       Impact factor: 3.215

8.  Pharmacokinetics of loxiglumide after single intravenous or oral doses in man.

Authors:  I Setnikar; R Chisté; F Makovec; L C Rovati; S J Warrington
Journal:  Arzneimittelforschung       Date:  1988-05

9.  Provocation of transient lower esophageal sphincter relaxations by meals in patients with symptomatic gastroesophageal reflux.

Authors:  R H Holloway; P Kocyan; J Dent
Journal:  Dig Dis Sci       Date:  1991-08       Impact factor: 3.199

10.  Role of CCK in regulation of pancreaticobiliary functions and GI motility in humans: effects of loxiglumide.

Authors:  W E Schmidt; W Creutzfeldt; A Schleser; A R Choudhury; R Nustede; M Höcker; R Nitsche; H Sostmann; L C Rovati; U R Fölsch
Journal:  Am J Physiol       Date:  1991-02
View more
  13 in total

1.  Effect of phasic contractions and tone of the proximal stomach on triggering of transient lower esophageal sphincter relaxation.

Authors:  M Allocca; R Penagini
Journal:  Dig Dis Sci       Date:  2004-05       Impact factor: 3.199

2.  Does impaired gallbladder function contribute to the development of Barrett's esophagus and esophageal adenocarcinoma?

Authors:  Ayman O Nassr; Syeda Nadia Shah Gilani; Mohammed Atie; Tariq Abdelhafiz; Val Connolly; Neil Hickey; Thomas Noel Walsh
Journal:  J Gastrointest Surg       Date:  2011-04-12       Impact factor: 3.452

3.  Is glutamate involved in transient lower esophageal sphincter relaxations?

Authors:  D P Hirsch; G N J Tytgat; G E E Boeckxstaens
Journal:  Dig Dis Sci       Date:  2002-03       Impact factor: 3.199

4.  Beyond acid suppression: new pharmacologic approaches for treatment of GERD.

Authors:  Paul Kuo; Richard H Holloway
Journal:  Curr Gastroenterol Rep       Date:  2010-06

5.  Role of CCK(A) receptors in postprandial lower esophageal sphincter function in morbidly obese subjects.

Authors:  D P Hirsch; E M H Mathus-Vliegen; R H Holloway; N Fakhry; M D'Amato; G E E Boeckxstaens
Journal:  Dig Dis Sci       Date:  2002-11       Impact factor: 3.199

6.  Diminished retention of food in the proximal stomach correlates with increased acidic reflux in patients with gastroesophageal reflux disease and dyspeptic symptoms.

Authors:  José Ruver L Herculano; Luiz E A Troncon; Lilian R O Aprile; Eder R Moraes; Marie Secaf; Pedro H C Onofre; Roberto O Dantas; Ricardo B Oliveira
Journal:  Dig Dis Sci       Date:  2004-05       Impact factor: 3.199

7.  Cholecystokinin induces esophageal longitudinal muscle contraction and transient lower esophageal sphincter relaxation in healthy humans.

Authors:  Arash Babaei; Ravinder Mittal
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-06-14       Impact factor: 4.052

Review 8.  Neuro-regulation of lower esophageal sphincter function as treatment for gastroesophageal reflux disease.

Authors:  Anupender Singh Sidhu; George Triadafilopoulos
Journal:  World J Gastroenterol       Date:  2008-02-21       Impact factor: 5.742

9.  Effects of octreotide on lower esophageal sphincter in patients with cirrhosis and portal hypertension.

Authors:  T Barrioz; C Borderie; P Strock; P Ingrand; E Fort; C Silvain; M Beauchant
Journal:  Dig Dis Sci       Date:  1998-07       Impact factor: 3.199

Review 10.  Progress with novel pharmacological strategies for gastro-oesophageal reflux disease.

Authors:  Marcello Tonini; Roberto De Giorgio; Fabrizio De Ponti
Journal:  Drugs       Date:  2004       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.